CardioGenics Holdings Inc. — Net Income by Fiscal Year
18 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/6e063a22-2d7c-4928-8f67-36f146f83195/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2015 | $-1.9M | 2014-11-01 – 2015-10-31 | evidence 0001493152-16-007687 |
| FY 2014 | $-2.7M | 2013-11-01 – 2014-10-31 | evidence 0001493152-15-000488 |
| FY 2013 | $-45.7M | 1997-11-20 – 2014-04-30 | evidence 0001493152-14-001924 |
| FY 2012 | $-42.5M | 1997-11-20 – 2013-04-30 | evidence 0001144204-13-043559 |
| FY 2011 | $-41.4M | 1997-11-20 – 2012-04-30 | evidence 0001144204-12-034570 |
| FY 2010 | $-2.0M | 2009-11-01 – 2010-10-31 | evidence 0001144204-12-004759 |
| FY 2009 | $-28.7M | 2008-11-01 – 2009-10-31 | evidence 0001144204-12-004759 |
| FY 2008 | $-1.3M | 2007-11-01 – 2008-10-31 | evidence 0001144204-12-004759 |
| FY 2007 | $-303.5k | 2006-11-01 – 2007-10-31 | evidence 0001144204-12-004759 |
| FY 2006 | $-522.5k | 2005-11-01 – 2006-10-31 | evidence 0001144204-12-004759 |
| FY 2005 | $-682.4k | 2004-11-01 – 2005-10-31 | evidence 0001144204-12-004759 |
| FY 2004 | $-592.7k | 2003-11-01 – 2004-10-31 | evidence 0001144204-12-004759 |
| FY 2003 | $-229.0k | 2002-11-01 – 2003-10-31 | evidence 0001144204-12-004759 |
| FY 2002 | $-156.2k | 2001-11-01 – 2002-10-31 | evidence 0001144204-12-004759 |
| FY 2001 | $-114.8k | 2000-11-01 – 2001-10-31 | evidence 0001144204-12-004759 |
| FY 2000 | $-152.5k | 1999-11-01 – 2000-10-31 | evidence 0001144204-12-004759 |
| FY 1999 | $-100.1k | 1998-11-01 – 1999-10-31 | evidence 0001144204-12-004759 |
| FY 1998 | $-81.2k | 1997-11-20 – 1998-10-31 | evidence 0001144204-12-004759 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
CardioGenics Holdings Inc. — all facts · Revenue · Operating Income